Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT04765085
Other study ID # Sunjinhua
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date March 2021
Est. completion date September 2022

Study information

Verified date February 2021
Source Children's Hospital of Fudan University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Study on the clinical efficacy and change of life quality through using the Comprehensive Behavioral Intervention Treatment for Tics (CBIT)


Description:

This study tried to explore the clinical effect of comprehensive behavioral intervention therapy (CBIT) on tic symptoms and the effect of improving the quality of life in children with tic disorders;explore the optimal treatment plan for tic disorder by comparing the clinical efficacy of CBIT therapy, drug therapy, and psychosocial education; explore the feasibility of using quality of life as an evaluation index for functional recovery after tic disorder treatment;


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date September 2022
Est. primary completion date June 2022
Accepts healthy volunteers No
Gender All
Age group 9 Years to 16 Years
Eligibility Inclusion Criteria: - Meets the diagnostic criteria for chronic tic disorder or Tourette syndrome (TS) according to the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-V), and has been diagnosed by two pediatric psychiatrists who are associate chief physicians or more; - The age ranged from 9 to 16 years old; - The total score of tic symptoms in the Yale global Tic Severity Scale (YGTSS) is 13-30; - Childrens Webster's Intelligence Scale = 85 - Co-morbid ADHD, but the drug treatment dose for ADHD is stable (the drug has been stabilized for more than 6 weeks), or no drug has been taken at the beginning and during the stud Exclusion Criteria: - There are brain organic diseases, metabolic diseases, psychiatric disorders, drug-induced involuntary movement and other extrapyramidal lesions; - Habit reversal training and other behavioral treatments for more than 4 weeks; - unwilling participants or disobedient subgroups in the study

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
comprehensive behavioral intervention therapy (CBIT)
Comprehensive behavioral intervention for tics is an extension of habit reversal training. It includes an expanded set of strategies, such as psycho-education about tic disorders, tic awareness training, competing response training, relaxation training, and functional analysis. According to the CBIT treatment manual (translated by sun Jinhua and Xu Wen, the author were Douglas W. woods et al., Oxford University Press, New York). The treatments consisted of 8 sessions for 10 weeks The first two phases were 1.5 hours, the last six stages were 1 hour.The treatment process was regularly supervised by a treatment supervisor.
Drug:
Aripiprazole 5Mg Oral Tablet
Considering the patients with chronic tic disorder (chronic motor or vocal tic disorder or Tourette's disorder), aripiprazole was selected as a single drug with constant dose during the treatment. In case of extrapyramidal side effects, benhexol was given to reduce the extrapyramidal side effects, and the dosage and duration of medication were recorded

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Children's Hospital of Fudan University

Outcome

Type Measure Description Time frame Safety issue
Primary Reduction rate of Tic symptom severity before and after intervention Tic symptom severity is estimated by Yale Global Tic Severity Scale Total Tic score. The YGTSS is a clinician-rated scale used to assess tic severity over the prior week. It includes a checklist of motor and vocal tics followed by an assessment of the number, frequency, intensity, complexity, and inference of motor tics and phonic tics-scored separately. Each of these dimensions is scored on a 0 to 5 scale. The YGTSS provides three tic severity scores: Total Motor (0 to 25); Total Phonic (0 to 25) and the combined Total Tic Severity Score (0 to 50), as well as a separate Impairment dimension scored from0 to 50. The Total Tic Score (YGTSS-TTS) was used in these analyses.Lower scores indicate improvement and higher scores indicate worsening.
Reduction rate = (YGTSS total score before intervention - YGTSS total score after intervention) / YGTSS total score before treatment × 100%
Baseline, the tenth week of treatment
Secondary overall treatment response The overall treatment response is measured by CG-I. This is a repeated measurement variable.The CGI-I was used to measure overall treatment response. The scores range from 1 (very much improved) to 4 (no change) to 7 (very much worse). We defined positive response as a score of 1 or 2 (much improved or very much improved). The fifth week and the tenth week of treatment and three month after treatment end
Secondary life quality Pediatric Quality of Life Inventory (PedsQL) and Child Tourette's Syndrome Impairment Scale(CTIM) were used to assessed health-related QoL.This is a repeated measurement variable.
PedsQL was a widely used 15-item measure assessed health-related QoL. Parents were asked to rate how often a particular item had been a problem during the past month using a 5-point Likert scale ranging from ''never a problem'' to ''almost always a problem." Total scores were linearly transformed to a scale of 0 to 100. Higher scores indicated better QoL. Four subscales measured physical, emotional, social, and school functioning.
The CTIM-P is a 37-item parent-rated instrument that includes school, home, and social activities that may be impaired by their child's tics or a co-morbid problem (e.g., obsessive-compulsive symptoms, depressed mood, anxiety, oppositional/disruptive behavior, hyperactivity, inattentiveness).
The fifth week and the tenth week of treatment and three month after treatment end
See also
  Status Clinical Trial Phase
Recruiting NCT05370391 - Comprehensive Behavioral Intervention for Tics N/A
Completed NCT04007913 - Incorporating teleCBIT Into a Hospital-Based Tic Program N/A
Completed NCT00241176 - Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder Phase 4
Completed NCT04498364 - Extinction Learning in Adults With Tourette Syndrome N/A
Recruiting NCT03844919 - TICS: Transcranial Magnetic Stimulation for Intervening in Children With Tourette's Syndrome (CIHR) N/A
Not yet recruiting NCT06081348 - Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders Phase 2
Completed NCT00231985 - Effectiveness of Behavior Therapy and Psychosocial Therapy for the Treatment of Tourette Syndrome and Chronic Tic Disorder Phase 2
Recruiting NCT06050369 - Objective Characterizatoion of Repetitive Behaviors N/A
Completed NCT04578912 - Transcranial Magnetic Stimulation to Augment Behavior Therapy for Tics N/A
Completed NCT03483493 - Online Remote Behavioural Intervention for Tics (ORBIT) N/A
Recruiting NCT06408662 - Remote Delivery of a Mindfulness-based Intervention for Tics N/A
Completed NCT02676492 - A Naturalistic Study Investigating Sleep and Cognitive Learning in Children With and Without Tic Disorders N/A
Recruiting NCT01860300 - Efficacy of Amoxicilline/Clavulanic Acid in Patients Affected by Tic Disorder Colonized by Group A Streptococcus N/A
Completed NCT00001667 - Genotype/Phenotype Correlation of Movement Disorders and Other Neurological Diseases N/A
Completed NCT00056420 - Brain Dynamics Involved in Generating Tics and Controlling Voluntary Movement N/A
Completed NCT04128397 - An Exploratory Study of Continuous Theta Burst Stimulation (cTBS) Based on fMRI in the Treatment of Tic Disorder N/A
Recruiting NCT05547854 - Evaluation of an Online Comprehensive Behavioral Intervention for Tics (CBIT) Therapist Training Program N/A
Completed NCT05047705 - Investigating Distress Tolerance in Adults With Tourette Syndrome N/A
Completed NCT03564132 - Evaluating the Efficacy and Safety of Yi-Gan San in Children and Adolescents With Tourette's Disorder Phase 2
Completed NCT03239210 - Effects of Ondansetron in Obsessive-compulsive and Tic Disorders Phase 4